HRH4 and neoplasm: This could partially explain the effects observed when 4T1 cells were treated with the highest concentration of H4R agonist, which may in the balance prevail over the direct antiproliferative effect on tumour cells, and thus it may be a determinant for the non-effective therapeutic outcome.